RX Partners Limited - Accounts to registrar (filleted) - small 18.2

RX Partners Limited - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v18.3.1.65 10839581 director 28.7.17 30.6.18 30.6.18 false true false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure108395812017-07-27108395812018-06-30108395812017-07-282018-06-30108395812017-07-2710839581ns15:EnglandWales2017-07-282018-06-3010839581ns14:PoundSterling2017-07-282018-06-3010839581ns10:Director12017-07-282018-06-3010839581ns10:PrivateLimitedCompanyLtd2017-07-282018-06-3010839581ns10:Micro-entities2017-07-282018-06-3010839581ns10:AuditExemptWithAccountantsReport2017-07-282018-06-3010839581ns10:FullAccounts2017-07-282018-06-3010839581ns5:CurrentFinancialInstruments2018-06-3010839581ns10:Director112017-07-2710839581ns10:Director112017-07-282018-06-3010839581ns10:Director112018-06-30


REGISTERED NUMBER: 10839581 (England and Wales)





















UNAUDITED FINANCIAL STATEMENTS FOR THE PERIOD 28 JULY 2017 TO 30 JUNE 2018

FOR

RX PARTNERS LIMITED

RX PARTNERS LIMITED (REGISTERED NUMBER: 10839581)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE PERIOD 28 JULY 2017 TO 30 JUNE 2018










Page

Chartered Accountants' Report 1

Balance Sheet 2


CHARTERED ACCOUNTANTS' REPORT TO THE DIRECTOR
ON THE UNAUDITED FINANCIAL STATEMENTS OF
RX PARTNERS LIMITED


The following reproduces the text of the report prepared for the director in respect of the company's annual
unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a
Balance Sheet. Readers are cautioned that the Income Statement is not required to be filed with the Registrar of
Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial
statements of RX Partners Limited for the period ended 30 June 2018 which comprise the Income Statement, Balance Sheet
and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the director of RX Partners Limited in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of RX Partners Limited and state those matters that we have agreed to state to the director of RX Partners Limited in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than RX Partners Limited and its director for our work or for this report.

It is your duty to ensure that RX Partners Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of RX Partners Limited. You consider that RX Partners Limited is exempt from the statutory audit requirement for the period.

We have not been instructed to carry out an audit or a review of the financial statements of RX Partners Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Lawfords Consulting Limited
Chartered Accountants
Union House
Walton Lodge
Bridge Street
Walton-on-Thames
Surrey
KT12 1BT


15 February 2019

RX PARTNERS LIMITED (REGISTERED NUMBER: 10839581)

BALANCE SHEET
30 JUNE 2018

£    £   
FIXED ASSETS 871

CURRENT ASSETS 93,766

CREDITORS
Amounts falling due within one year (86,526 )
NET CURRENT ASSETS 7,240
TOTAL ASSETS LESS CURRENT
LIABILITIES

8,111

CAPITAL AND RESERVES 8,111

NOTES TO THE FINANCIAL STATEMENTS

1. STATUTORY INFORMATION

RX Partners Limited is a private company, limited by shares , registered in England and Wales. The company's
registered number and registered office address are as below:

Registered number: 10839581

Registered office: 33 Bruton Place
London
W1J 6NP

The presentation currency of the financial statements is the Pound Sterling (£).


2. AVERAGE NUMBER OF EMPLOYEES AND DIRECTORS

The average number of employees during the period was 1 .

3. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the period ended 30 June 2018:

£   
R M Hatcher
Balance outstanding at start of period -
Amounts advanced 87,435
Amounts repaid (42,587 )
Balance outstanding at end of period 44,848

The advance has been charged at 2.5%. The loan is unsecured and repayable upon demand.



RX PARTNERS LIMITED (REGISTERED NUMBER: 10839581)

BALANCE SHEET - continued
30 JUNE 2018


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 30 June 2018.

The members have not required the company to obtain an audit of its financial statements for the period ended 30 June 2018 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act
2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394
and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements,
so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

The financial statements were approved by the director on 29 January 2019 and were signed by:





R M Hatcher - Director